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Abstract: Tremor is a prominent phenotype of the twitcher mouse, an authentic genetic 
model of Globoid-Cell Leukodystrophy (GLD, Krabbe’s disease). In the current study, the 
tremor was quantified using a force-plate actometer designed to accommodate low-weight 
mice. The actometer records the force oscillations caused by a mouse’s movements, and 
the rhythmic structure of the force variations can be revealed. Results showed that twitcher 
mice had significantly increased power across a broad band of higher frequencies 
compared to wildtype mice. Bone marrow transplantation (BMT), the only available 
therapy for GLD, worsened the tremor in the twitcher mice and induced a measureable 
alteration of movement phenotype in the wildtype mice. These data highlight the damaging 
effects of conditioning radiation and BMT in the neonatal period. The behavioral 
methodology used herein provides a quantitative approach for assessing the efficacy of 
potential therapeutic interventions for Krabbe’s disease.  
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1. Introduction 
Globoid-cell leukodystrophy (GLD; Krabbe’s disease) is a rapidly progressive demyelinating 
disease caused by the deficiency of the lysosomal enzyme Galactosylceramidase (GALC) [1]. The 
disease is characterized by prominent CNS symptoms including delayed development, spasticity, and 
seizures. In humans, the age of onset of symptoms is usually around 6 months, with inevitable 
progression and death by around 2–3 years of age. Currently, the only available treatment in humans is 
bone marrow transplantation (BMT). Although BMT can be relatively effective if initiated in  
pre-symptomatic patients, it is not a cure and treated children continue to develop clinical signs. One 
important question is: are the continually progressing clinical signs due to GALC deficiency or are 
they treatment-related? 
The murine model used to study GLD is the twitcher mouse which is deficient in the same enzyme 
as that of humans [2,3]. The eponymous and characteristic feature of the murine model is severe 
twitching or tremor. Other phenotypic features include decreased body weight, hindlimb ataxia, decreased 
mobility and a shortened lifespan. Similar to the human disease, the neuropathology consists of 
demyelination, axonal damage [4,5] with prominent inflammation, and the accumulation of lipid-laden 
macrophages (globoid-cells) throughout the CNS and the PNS. Although tremor is a prominent 
phenotype in the twitcher mouse, it has not been thoroughly characterized. Also, little is known about 
how the tremor is altered after various treatments, especially BMT following harsh conditioning 
regimens. In the current study, a detailed phenotypic characterization of the tremor in the twitcher 
mouse was performed using a force-plate actometer [6] that allowed recording of the movement-
related force generated by small (7–13 g) mice. The power spectra and the locomotor activity of the 
twitcher mice were compared to the wildtype mice to reveal several important differences. The study 
also evaluated the effect of BMT on tremor and locomotor activity in both the twitcher and wild type 
mice. The results demonstrate that BMT and the harsh conditioning regimens associated with this 
procedure can superimpose additional clinical defects on this already devastating disease.  
2. Methods 
2.1. Colony Maintenance 
Galc+/− and wildtype mice on the C57BL/6J background were obtained from The Jackson 
Laboratory (Bar Harbor, ME) and maintained under the supervision of M.S.S. at Washington 
University School of Medicine. The galc−/− mice were obtained by galc+/− × galc+/− matings. The 
galc genotype was determined by twitcher-specific PCR [7]. All animals were allowed ad libitum 
access to food and water, except during brief (12-min or less) behavioral recording sessions. All 
animal experiments were approved by Institutional Animal Care and Use Committee at Washington 
University School of Medicine.  
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2.2. BMT and Harmaline Injections 
Neonatal pups were genotyped on day 2 or 3 and BMT was performed on post natal day 3 or 4. The 
mice received 400 rads of total body irradiation from a 137Cs source. The animals received an 
intravenous injection of 106 nucleated bone marrow cells from a sex-matched galc+/+, GFP (+)  
donor [8] via the superficial temporal vein [9]. 
Harmaline (1-methoxy-3,4-dihydro-β-carboline, H1392, Sigma, St. Louis, MO) at a dose of 15 mg/kg 
was injected intraperitoneally 12 min before the start of tremor monitoring on post natal day 36.  
The nomenclature for the various treatment groups and the number of animals used in the study is 
as follows: (a) Wt—untreated wildtype (n = 28), (b) Twi—untreated mutant (twitcher; n = 34), (c) 
BmtWt—wildtype mice treated with BMT (n = 12), (d) BmtTwi—twitcher mice treated with BMT  
(n = 7), (e) WtH—wildtype mice treated with harmaline (n = 11), (f) TwiH—twitcher mice treated 
with harmaline (n = 8), (g) BmtWtH—BmtWt mice treated with harmaline (n = 11), and (h) 
BmtTwiH—BmtTwi mice treated with harmaline (n = 7).  
2.3. Bone Marrow Engraftment 
Since the current study was an extension of the previous study (Reddy et al., 2011), and there was 
an overlap in the animals that were used in the abovementioned study with the current study. The 
engraftment levels from the various groups are described in results.  
2.4. Force Plate Actometer 
The design of the force plate actometer and the principles used in the design were described 
previously [6]. For the current study a force-plate actometer was custom made to accommodate the 
relatively low body weight and impaired force production capabilities of the untreated twitcher mice. 
The mean weight of the twitcher mice at 36 days was 10.4 ± 1.6 g compared to 16.9 ± 1.8 g for 
wildtype mice at this age. The custom-made actometer used a carbon fiber/nomex composite material 
for the load plate, which weighed 57 g, was 3.2 mm thick and measured 24 cm × 24 cm. The sensing 
area was 20 cm × 20 cm, and the cage that confined the mouse to the load plate was constructed of  
6.4 mm-thick clear polycarbonate with inside dimensions of 20 cm long by 20 cm wide by 15 cm high. 
A removable clear polycarbonate top was perforated with ventilation holes. The load plate was 
supported by four Model 31a miniature strain gauge load cells purchased from Honeywell/Sensotec 
(Columbus, Ohio). The load cells were calibrated to yield a force resolution of 0.2 gram-force.  
2.5. Actometer Data Acquisition and Analysis 
The animals were acclimated for at least 30 min in the same room prior to tremor monitoring. Data 
recording was conducted between 2 p.m. and 6 p.m. For mice given harmaline, the drug or saline was 
injected 12 min prior to recording. Data were collected for 6 min, but only the first minute, when 
movement was maximal, was used for the tremor analyses. The recordings from the transducers were 
collected at 100 samples/s. The 12-bit integer raw data files were acquired with a LabMaster interface 
(Scientific Solutions, Mentor, Ohio) that was controlled by a DOS-based Free Pascal program 
(http://www.freepascal.org). The data from the raw integer files were converted to text files and 
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formatted by Free Pascal programs for further processing by commercially available software (see 
Statistics section below). Custom written Free Pascal programs were used to calculate distance 
traveled and the number of low mobility bouts (see below).  
The following data were extracted from the raw data files [6]: (a) Fz—the net force exerted by the 
animal at a particular 0.01-s “instant” was calculated as the sum forces on each of the four transducers 
that supported the load plate. The digitized Fz data obtained at 100 samples/s for the first minute of the 
recording session were formatted into 12 consecutive 5.00-s time series. Importantly, for the tremor 
analyses the Fz time series data were expressed as a percent of each mouse’s body weight. This 
normalization made it possible to compare the power spectra across genetic and treatment conditions 
without potential confounding by the body weight differences. Each time series (Fz(t)) was Fourier 
transformed using the fft function in MATLAB (The Mathworks, Inc., Natick, MA). A 500-point 
Hanning time-domain data window was used. The resulting 12 power spectra were averaged together 
to yield a single power spectrum for each mouse. The individual frequencies obtained after Fourier 
transformation were plotted as a continuous function (power spectrum; see Figure 1C) after filtering 
to retain frequencies between 2.5 and 30.0 Hz. (b) The bandwidth was defined as the difference 
between the upper and lower limit of the frequencies where the power was half that of the maximum. 
(c) The center frequency was calculated as the frequency co-ordinate of the vertical line bisecting the 
bandwidth. (d) The frequency at peak power was taken as the frequency at which the power was at 
its maximum. (e) Power between 13 and 20 Hz was obtained by integrating the area under the power 
spectrum curve between 13 and 20 Hz. The aforementioned power spectrum variables (a–e) were 
computed for each individual mouse, and these variables were then subjected to standard statistical 
treatments (see below).  
Although the tremor analyses were performed for the first minute of force-plate recordings, the 
variables for tracking and quantifying the mouse’s horizontal movements in the actometer were based 
on the entire 6-min session. (f) The X-Y position of the mouse on the force plate and (g) the distance 
traveled by the animal was calculated using the principle of moments and by calculating distance  
(in mm) between centers of force locations at successive time points 0.5 s apart, respectively [6]. The 
X-Y locations of the animal at various time points were plotted as a function of time to obtain the (h) 
trajectory of animal movement. (i) X-Y coordinates of the center of force as a function of time were 
additionally used to identify a low mobility bout, which was defined in terms of a virtual circle with a 
radius of 15.0 mm that was centered on the mouse as it moved across the load plate. When 5.00 s 
elapsed without movement beyond the perimeter of the circle, a low mobility bout was tallied, and the 
5.00-s time interval was reset to 0 in order to “look for” the next bout. This measure gives an 
indication of a mouse’s proclivity to “stay in one place” regardless of the location of that place on the 
load plate. 
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Figure 1. Characterization of tremor in the Twi mice. Representative Fz time series 
recording from a Wt mouse (A) and a Twi mouse (B) over 12 seconds (each series is  
6 s). The X-axis represents time and the Y-axis represents force the vertical force variation 
(Fz) recorded by the force plate actometer. A Fourier transformation performed on the Fz 
time series data yields a power spectrum that shows how much power (variance) the Fz 
variation contains at each frequency of oscillation. The power spectrum can then be further 
analyzed to yield peak power, frequency at peak power, center frequency, and bandwidth. 
These data are represented diagrammatically on a hypothetical power spectrum plot (C). 
The averaged power spectrum (D) of the Twi mice (solid black line) was shifted towards 
higher frequencies compared to the Wt mice (dashed gray line). The center frequency (E) 
was significantly increased in the Twi (open circles) compared to the Wt mice (filled 
squares). There was a significant increase in the band width (F) in the Twi compared to the 
Wt group. The peak power (G), frequency at peak power (H) and the power between 13 
and 20 Hz (I) were significantly increased in the Twi group compared to the Wt group. The 
horizontal bars represent the mean and the error bars represent the SEM (*** p < 0.001,  
** p < 0.01). 
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2.6. Statistical Analyses 
Systat (Systat Software Inc., Chicago, IL, USA) and Graphpad prism (Graphpad Software, Inc.,  
La Jolla, CA) were used for generating graphs and performing statistical analyses. ANOVA or  
Kruskal-Wallis tests were used to compare different groups, and post-hoc multiple comparisons were 
done using Bonferroni tests. 
3. Results 
3.1. Tremor and Locomotion in Twitcher Mice  
The qualitative differences in the Fz time series between the Wt and Twi mice are shown in  
Figure 1A,B. A Fourier transform was applied to the Fz time series to obtain a power spectrum  
(Figure 1C). The power spectra of different animals were further analyzed to obtain the peak power, 
frequency of peak power, center frequency, and bandwidth (Figure 1C). The averaged power spectra 
(Figure 1D) showed that the Twi mice had substantially higher power at higher frequencies compared 
to the Wt mice. The center frequency and the bandwidth in the Twi group were significantly higher 
than these variables for the Wt group (Figure 1E,F). The peak power (Figure 1G), frequency of peak 
power (Figure 1H), and the integrated power between 13 and 20 Hz (Figure 1I) were significantly 
increased in the Twi group compared to the Wt group (p < 0.001 for all three comparisons; t-test). The 
data for the Wt group are indicative of normal movements without any visible tremor, whereas the Twi 
mice exhibited the obvious tremor for which they are named. This analysis shows that the tremor of 
the twitcher mice manifests itself as relatively broad band, high-frequency force oscillations while on 
the force-plate. 
Figure 2. Characterization of locomotor activity in the twitcher mouse. The movement 
trajectory of representative Wt and Twi mice are shown in (A) and (B), respectively. Each 
panel represents the movement of the mouse for duration of 1 min. The box in which each 
movement trajectory is plotted represents the inside wall of the 20 cm × 20 cm cage that 
confined the mouse to the load plate. Each point in the panel represents the XY location of 
the mouse at a certain point of time. The total distance traveled during 6 min is shown  
in (C). The total distance traveled by the Wt mice (filled squares) is significantly higher 
than that of the Twi mice (open circles). The horizontal bars represent the mean and the 
error bars represent the SEM (*** p < 0.001). 
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The Twi group had decreased locomotion compared to that of the Wt group. Representative 
trajectories of these two groups are shown in Figure 2A,B. The total distance traveled was significantly 
lower in the Twi group compared to the Wt group (p < 0.001, t-test; Figure 2C). 
One way to validate the tremor recorded by this newly developed actometer is by comparing it to a 
relatively well accepted pharmacological tremor model (harmaline treatment) [10]. Therefore, the 
tremor in the Twi mouse was compared to the tremor in the wildtype mice injected with harmaline 
(WtH). Harmaline induces a characteristic narrow-band, near 12-Hz tremor. Comparison of the Twi 
and the WtH animals revealed a robust between-group difference in the averaged power spectra 
(Figure 3A). As quantified in terms of the mean of the center frequencies, the Twi mice (15.8 Hz) had 
significantly higher values than the WtH group (12.2 Hz) (p < 0.001; Bonferroni test, Figure 3B). The 
WtH group had a near-12.2 Hz narrow peak, and the bandwidth was significantly less than that of the 
Twi group (p < 0.001; Bonferroni test, Figure 3C). There was no statistically significant difference 
between the distance traveled and the number of low mobility bouts between the WtH and the 
Twigroups (data not shown), probably because tremor-inducing doses of harmaline in intact animals 
suppresses locomotion [10].  
Interestingly, when twitcher mice were injected with harmaline (TwiH), there was a blunted 
response with no statistically significant change in center frequency or bandwidth compared to the Twi 
group (Figure 3B,C). In the WtH group, the peak power was significantly higher (p < 0.001; 
Bonferroni test; Figure 3D) while frequency of peak power was significantly lower (p < 0.05; 
Bonferroni test; Figure 3E) compared to the Twi group. There was no significant difference between 
the TwiH and WtH groups with respect to the distance traveled or the number of low mobility bouts 
(data not shown).  
3.2. Effect of Treatment on Tremor 
In order to directly assess the effect of myeloreductive conditioning and BMT on the power spectra, 
tremor quantification was performed on both wildtype and twitcher mice that received BMT (BmtWt 
versus BmtTwi). The engraftment in various groups is essentially as reported in the study by  
Reddy et al., 2011. BmtWt group had a mean +/− standard error engraftment of 20.52 +/− 3.077, 
BmtTwi group was at 12.1 +/− 1.9 and the AAVBMT group was 16.09 +/− 4.0. The engraftment level 
in the untransplanted animals was less than 1%.  
The BmtWt group had greater power in both the frequencies around 10–12 Hz and in the higher 
frequencies in the 13–20 Hz range compared to the Wt group (Figure 4A). The BmtTwi group had 
greater power in the near 10 Hz lower frequency range compared to the Twi group. The center 
frequency of the BmtWt group was significantly increased compared to the Wt group (p < 0.01; 
Bonferroni test; Figure 4B). The bandwidth variable (data not shown) did not indicate any significant 
between-group effects. The peak power (Figure 4C) and the power between 13 and 20 Hz (Figure 4E) 
was significantly increased in the BmtWt group compared to the Wt group but not in the BmtTwi 
group compared to the Twi group. The frequency of peak power was not significantly different in the 
BmtWt group compared to the Wt group (Figure 4D). There was no significant difference in the 
frequency of peak power between the BmtTwi group and the Twi group (Figure 4D). The total  
J. Clin. Med. 2012, 1 
 
8
distance traveled was significantly decreased (decrement in normal function) in the BmtWt group 
compared to the Wt group (Figure 4F).  
Figure 3. Comparison of the tremor of the Twi mice with that of the tremor induced 
by harmaline. The average power spectrum (A) of the Twi mice (solid black line) 
reflected a broadband tremor and that of the WtH mice (solid gray line) showed a 
characteristic narrow band 12 Hz tremor. The response to harmaline was blunted in the 
TwiH mice (dashed black line). The center frequency (B) and bandwidth (C) were 
significantly increased in the Twi group (open circles) compared to the WtH group (filled 
diamonds), which exhibited the expected characteristic narrow band tremor typically 
induced by harmaline in mice. The peak power (D) was significantly increased in the WtH 
group compared to the Twi group. The frequency at peak power was significantly 
decreased in the WtH group compared to the Twi group. There was no significant 
difference in the center frequency, bandwidth, peak power and the frequency of peak 
power between the Twi and TwiH groups (plus symbols). Horizontal bars represent the 
mean and the error bars represent the SEM (*** p < 0.001, ** p < 0.01 and * p < 0.05). 
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Figure 4. Effect of BMT on power spectra. The averaged power spectrum (A) of the 
BmtWt group (dashed gray line) is shifted upward and rightward compared to the Wt 
group (solid gray line). Similarly, the averaged power spectrum in the BmtTwi group 
(dashed black line) is shifted upward across a broad frequency band compared to the Twi 
group (solid black line). The center frequency (B) was significantly increased in the 
BmtWt group (open triangles) compared to the Wt group (filled squares). There was no 
significant difference between the untreated mut (open circles) and BmtTwi groups (cross 
marks) in the center frequency. The peak power (C), frequency of peak power (D) and the 
power between 13 and 20 Hz (E) was significantly increased in the BmtWt group 
compared to the Wt group. Compared to the Twi group, the BmtTwi group showed no 
significant difference in the center frequency (B), peak power (C), frequency of peak 
power (D) and power between 13 and 20 Hz (E). The distance traveled by the BmtWt 
group was significantly decreased compared to the Wt group (F). The horizontal bars 
represent the mean and the error bars represent SEM (*** p < 0.001, ** p < 0.01 and  
* p < 0.05).  
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3.3. Harmaline Response in BMT Animals  
The BMT-treated animals that had additional higher frequencies in the averaged power spectra 
were compared to mice that received harmaline after BMT (BmtWtH and BmtTwiH). Interestingly, 
the mice in the BmtWtH group were more resistant to harmaline-induced tremors than the WtH group 
(Figure 5A). The response to harmaline in the BmtTwiH group was similar to the TwiH group  
(Figure 5A). The center frequency was higher and the bandwidth was broader in the BmtWtH group 
compared to the WtH group (Figure 5B,C). The peak power was significantly lower in the BmtWtH 
group compared to the WtH group (Figure 5D). There was no significant difference in the center 
frequency, bandwidth and peak power between the TwiH and BmtTwiH groups (Figure 5B–D). There 
was no significant difference in the distance traveled or in the number of low mobility bouts in the 
groups compared in Figure 5 (data not shown).  
Figure 5. Harmaline tremor response in the BMT-treated animals. Averaged power 
spectra of various groups treated with harmaline (A). The averaged power spectrum of 
WtH group (solid gray line) appears different compared to the averaged power spectrum of 
the other groups in (A). The averaged power spectra of the BmtWtH (solid black line), 
TwiH (dashed black line), and BmtTwiH (solid gray line) appear very similar to each 
other. The center frequency (B) and the bandwidth (C) were significantly increased in the 
BmtWtH group (open triangles) compared to the WtH group (filled squares). The peak 
power (D) was significantly decreased in the BmtWtH group compared to the WtH group. 
There was no significant difference in center frequency, bandwidth or peak power between 
the TwiH (open circles) and BmtTwiH groups (cross marks). Horizontal bars represent the 
mean and the error bars represent the SEM (*** p < 0.001, ** p < 0.01 and * p < 0.05). 
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3.4. Cerebellar Pathology  
The brains of the various treatment groups were evaluated for the presence of globoid cells 
(multinucleated macrophages with storage material) and myelination using Periodic acid-Schiff (PAS) 
and Luxol fast blue (LFB) staining, respectively (Figure 6). When stained for PAS, the cerebellar 
white matter from a Wt mouse shows no globoid cells (Figure 6A), in contrast the brain from a Twi 
mouse contains a large number of multinucleate cells with pink staining cytoplasm (Figure 6B, 
arrowheads). There is no apparent decrease in the number of globoid cells in the BmtTwi mouse 
compared to the Twi mouse (Figure 6C). When the brains are stained for LFB, the Wt group shows 
uniform myelination in the cerebellar white matter (asterisk in Figure 6D). In contrast, the architecture 
of the myelin in the Twi group appears less well organized, probably secondary to inflammatory 
edema (Figure 6E). In the BmtTwi group, the myelin remains disorganized, similar to that observed in 
the Twi group (Figure 6F). 
Figure 6. Histology—PAS and LFB staining. There are no identifiable PAS-positive 
cells in the cerebellum of the Wt animal (A). In the Twi (B), there are numerous pink 
multinucleated globoid cells (arrowheads). There is no obvious decrease in the number of 
PAS-positive cells in the BmtTwi group (C). Comparison of LFB staining in the cerebellar 
white matter (asterisk in D–F) and cerebellar folia shows a disruption of myelin 
architecture (blue staining) in the Twi (E) mouse compared to the Wt (D) animal. In the 
BmtTwi group (F), the myelin architecture remains disrupted, similar to the Twi group. 
 
4. Discussion 
In the current study, a detailed quantitative characterization of the tremor phenotype  
(movement-related force oscillations) in the twitcher mice was performed using a force-plate 
actometer. The tremor in the twitcher mouse was seen as increased power at relatively higher 
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frequencies with a broader bandwidth than the movement-related force oscillations exhibited by the 
wildtype mice moving normally on the force plate. An incidental finding in these studies was that the 
stereotypical tremor produced by harmaline was significantly altered in the twitcher mice. Harmaline 
is believed to disrupt the olivocereballar circuits [11]. The altered response of twitcher mice to 
harmaline is consistent with the deficiency of GALC leading to inflammation and demyelination in the 
white matter tracts of the cerebellum [12,13] including the olivocerebellar nucleus.  
The validity of tremor monitoring in evaluating the effects of various therapies was also 
determined. Hematopoietic stem cell transplantation (either using umbilical cord blood or bone 
marrow) is the only available therapy for Krabbe’s disease in humans [14,15]. Bone marrow 
transplantation also prolongs the lifespan in the twitcher mouse [12,16,17]. However, the effect of 
radiation conditioning (in preparation for BMT) and transplantation of donor bone marrow cells on the 
prominent tremor phenotype exhibited by the twitcher mouse had not heretofore been determined. 
Twitcher mice receiving BMT had power spectra that had greater power in higher frequencies, 
implying a worsening of tremor. This is contradictory to what is observed in terms of other measures 
like lifespan seen in previous studies [12,13]. Interestingly, wildtype animals receiving only BMT also 
had altered power spectra and were resistant to the effects of harmaline compared to the wildtype 
animals that did not receive BMT. Bone marrow transplantation using myeloreductive conditioning 
(400 rads of total body irradiation) is known to cause cerebellar dysplasia in neonatal mice [18]. The 
blunted response of the harmaline-treated animals receiving BMT is also consistent with the 
conditioning regimen causing cerebellar damage, including the olivocerebellar nucleus. Conditioning 
and BMT could also be adversely affecting some as yet unknown regions in the brain or periphery to 
give the same abnormal response. The current study thus highlights a possible harmful effect of 
conditioning in treating the disease. These effects could be explained by the presence of rapidly 
proliferating cells in the cerebellum during the time of conditioning and BMT [19]. Although, the 
current study uses myeloreductive conditioning at post natal day 3 or 4, similar and perhaps more 
severe function-compromising effects could be expected in studies that use fully myeloablative 
regimens [16,17]. Although conditioning regimens used in newborn children [15] typically do not 
involve ionizing radiation, the myeloablative drugs are nonetheless highly toxic and may superimpose 
additional abnormal phenotypes on the already complex Krabbe’s disease presentation. This could 
further complicate the interpretation of the therapeutic benefits of BMT for GLD.  
This study establishes the use of a custom-built, ultra-sensitive force-plate actometer in evaluating 
the effects of various therapies for the twitcher mice. It also emphasizes the need to evaluate the 
impact of various therapeutic approaches on a wide variety of functions before drawing conclusions on 
their safety and efficacy.  
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